Published Date: 24 Apr 2023
The revised schedule for the admissions entrance exam and application status has been made public by the All India Institute of Medical Sciences (AIIMS Delhi).
Read Full NewsBy analyzing data from three clinical trials treating children with the brain tumor medulloblastoma, scientists at St. Jude Children's Research Hospital have designed an approach to safely reduce therapy, thereby lowering ...
Radiotherapy can be safely omitted as a treatment for many breast cancer patients who have had a mastectomy and are taking anti-cancer drugs, a study shows.
People diagnosed with advanced breast cancer in 2025 can expect to live for an extra six or seven months, compared to the average survival time for patients diagnosed in 2011, according to a major study of patient data in ...
1.
According to research, hospitals can save money and help cancer patients by implementing a basic intervention.
2.
When it comes to LBCL relapse in complete remission, ASCT outperforms CAR T-cell therapy.
3.
FDA Approves Hemophilia B Second Gene Therapy.
4.
Insurance Claim Denials for Preventive Care More Common in At-Risk Patients
5.
Doctor Suspected of Murder; Cancer Blood Test Under Fire; TikTok and Body Image
1.
Exploring Innovative Solutions for Infantile Hemangioma Treatment
2.
Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage
3.
Mechanisms, Efficacy, and Survival Outcomes in AML, Squamous Cell Carcinoma, & Non-Hodgkin Lymphoma
4.
Understanding Vaso Occlusive Crisis: Symptoms, Causes, and Management Strategies
5.
Hemophilia: Pathophysiology, Genetics, and Treatment Advances
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion
2.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
3.
CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC
4.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
5.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation